Avaliar o Medo de Recorrência do Cancro em Adolescentes e Jovens Adultos: A Validação Portuguesa e Avaliação Psicométrica da Escala “Medo de Recorrência do Cancro 7”

Autores

  • Maria Carolina Neves Center for Psychology. Faculty of Psychology and Education Sciences. Universidade do Porto. Porto. Portugal. https://orcid.org/0000-0001-6976-5210
  • Célia M. D. Sales Center for Psychology. Faculty of Psychology and Education Sciences. Universidade do Porto. Porto. Portugal. https://orcid.org/0000-0002-2586-8469
  • Joana Oliveira Department of Education and Psychology. Campus Universitário de Santiago. Universidade de Aveiro. Aveiro. Portugal.
  • Ana Bártolo CINTESIS@RISE. Universidade Portucalense. Porto. Portugal. https://orcid.org/0000-0002-0817-0157
  • Judith B. Prins Department of Medical Psychology. Radboud University Medical Centre. Nijmegen. The Netherlands. https://orcid.org/0000-0001-5720-6091
  • Sara Monteiro CINTESIS@RISE. Department of Education and Psychology. Campus Universitário de Santiago. Universidade de Aveiro. Aveiro. Portugal; Department of Social Sciences and Management. Universidade Aberta. Lisboa. Portugal; Center for Global Studies. Universidade Aberta. Lisboa. Portugal. https://orcid.org/0000-0002-1389-3851

DOI:

https://doi.org/10.20344/amp.22085

Palavras-chave:

Adolescente, Adulto Jovem, Inquéritos e Questionários, Medo/psicologia, Psicometria, Recidiva Local de Neoplasia/psicologia, Reprodutibilidade dos Resultados

Resumo

Introdução: Os adolescentes e jovens adultos com cancro experienciam níveis elevados de medo da recorrência do cancro (FCR), podendo ter um impacto negativo nas suas vidas. Contudo, ainda nenhuma medida foi validada para avaliar os níveis de FCR nestes jovens a nível mundial. Este estudo tem como objetivo validar a FCR7, uma escala que mede o FCR, para a população portuguesa de adolescentes e jovens adultos.
Métodos: Noventa e dois participantes foram recrutados online. Eram maioritariamente mulheres (83,7%), com uma idade média de 26,01 anos no momento do recrutamento e de 19,38 anos no momento do diagnóstico de cancro, com uma variedade de diagnósticos de cancro e tratamentos anteriores. A maioria dos participantes já não se encontrava em tratamento ativo (75%) e tinham passado aproximadamente 75,1 meses desde o diagnóstico. Os níveis de FCR, ansiedade e depressão e qualidade de vida foram avaliados.
Resultados: Os resultados mostraram que a escala FCR7 tem um bom ajuste e fiabilidade. As validades concorrentes e divergentes foram também confirmadas, com o FCR correlacionando-se positivamente com a ansiedade e negativamente com a qualidade de vida. Um ponto de corte foi identificado, permitindo discriminar entre níveis clínicos e não clínicos de FCR. Quase 70% dos participantes apresentaram níveis clínicos de FCR.
Conclusões: Conclui-se que a FCR7 é uma escala unidimensional válida para avaliar os níveis de FCR nos adolescentes e jovens adultos portugueses. É importante haver mais investigação para validar medidas de FCR para esta população mundialmente. A existência de uma medida válida e breve para avaliar o FCR entre os adolescentes e jovens adultos em Portugal é uma mais-valia tanto para os profissionais de saúde, como para os investigadores nacionais.

Downloads

Não há dados estatísticos.

Referências

Lebel S, Ozakinci G, Humphris G, Mutsaers B, Thewes B, Prins J, et al. From normal response to clinical problem: definition and clinical features of fear of cancer recurrence. Support Care Cancer. 2016;24:3265-8.

Almeida SN, Elliott R, Silva ER, Sales CM. Fear of cancer recurrence: a qualitative systematic review and meta-synthesis of patients’ experiences. Clin Psychol Rev. 2019;68:13-24.

Simard S, Thewes B, Humphris G, Dixon M, Hayden C, Mireskandari S, et al. Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv. 2013;7:300-22.

Lee-Jones C, Humphris G, Dixon R, Hatcher MB. Fear of cancer recurrence - a literature review and proposed cognitive formulation to explain exacerbation of recurrence fears. Psychooncology. 1997;6:95- 105.

Custers JA, Gielissen MF, de Wilt JH, Honkoop A, Smilde TJ, van Spronsen DJ, et al. Towards an evidence-based model of fear of cancer recurrence for breast cancer survivors. J Cancer Surviv. 2017;11:41-7.

Mutsaers B, Butow P, Dinkel A, Humphris G, Maheu C, Ozakinci G, et al. Identifying the key characteristics of clinical fear of cancer recurrence: an international delphi study. Psychooncology. 2020;29:430-6.

Lim E, Humphris G. The relationship between fears of cancer recurrence and patient age: a systematic review and meta-analysis. Cancer Rep. 2020;3:1-14.

Luigjes-Huizer YL, Tauber NM, Humphris G, Kasparian NA, Lam WW, Lebel S, et al. What is the prevalence of fear of cancer recurrence in cancer survivors and patients? A systematic review and individual participant data meta-analysis. Psychooncology. 2022;31:879-92.

Adolescent and Young Adult Oncology Progress Review Group. Closing the gap: research and care implications for adolescents and young adults with cancer. 2006. [cited 2024 Jun 28]. Available from: https:// www.cancer.gov/types/aya/research/ayao-august-2006.pdf.

Yang Y, Li W, Wen Y, Wang H, Sun H, Liang W, et al. Fear of cancer recurrence in adolescent and young adult cancer survivors: systematic review of the literature. Psychooncology. 2019;28:675-86.

Sun H, Yang Y, Zhang J, Liu T, Wang H, Garg S, et al. Fear of cancer recurrence, anxiety and depressive symptoms in adolescent and young adult cancer patients. Neuropsychiatr Dis Treat. 2019;15:857-65.

Horwood M, Loades ME, Kosir U, Davis C. Illness perceptions, fear of cancer recurrence, and mental health in teenage and young adult cancer survivors. J Pediatr Hematol Oncol Nurs. 2024;41:44-55.

Vandraas KF, Reinertsen KV, Kiserud CE, Lie HC. Fear of cancer recurrence among young adult cancer survivors—exploring long-term contributing factors in a large, population-based cohort. J Cancer Surviv. 2021;15:497-508.

Schapira L, Zheng Y, Gelber SI, Poorvu P, Ruddy KJ, Tamimi RM, et al. Trajectories of fear of cancer recurrence in young breast cancer survivors. Cancer. 2022;128:335-43.

What should the age range be for AYA oncology? J Adolesc Young Adult Oncol. 2011;1:3-10.

McCarthy MC, McNeil R, Drew S, Dunt D, Kosola S, Orme L, et al. Psychological distress and posttraumatic stress symptoms in adolescents and young adults with cancer and their parents. J Adolesc Young Adult Oncol. 2016;5:322-9.

European Comission. Europe’s beating cancer plan: communication from the commission to the european parliament and the council. 2021. [cited 2024 Dec 15]. Available from: https://health.ec.europa.eu/system/ files/2022-02/eu_cancer-plan_en_0.pdf.

Instituto Português de Oncologia do Porto Francisco Gentil. Registo oncológico nacional de todos os tumores na população residente em Portugal, em 2020. 2023. [cited 2024 Dec 15]. Available from: https:// ron.min-saude.pt/media/2223/ron-2020.pdf.

Instituto Português de Oncologia Francisco Gentil. Registo oncológico nacional 2001. 2008. [cited 2024 Dec 15]. Available from: https://ron. min-saude.pt/media/1598/ron-2001.pdf.

Zebrack BJ. Psychological, social, and behavioral issues for young adults with cancer. Cancer. 2011;117:2289-94.

Richter D, Clever K, Mehnert-Theuerkauf A, Schönfelder A. Fear of recurrence in young adult cancer patients—a network analysis. Cancers. 2022;14:1-12.

Smith AW, Seibel NL, Lewis DR, Albritton KH, Blair DF, Blanke CD, et al. Next steps for adolescent and young adult oncology workshop: An update on progress and recommendations for the future. Cancer. 2016;122:988-99.

Costa DS, Smith A “Ben”, Fardell JE. The sum of all fears: conceptual challenges with measuring fear of cancer recurrence. Support Care Cancer. 2016;24:1-3.

Humphris GM, Watson E, Sharpe M, Ozakinci G. Unidimensional scales for fears of cancer recurrence and their psychometric properties: the FCR4 and FCR7. Health Qual Life Outcomes. 2018;16:1-12.

Lee YH, Hu CC, Humphris G, Huang IC, You KL, Jhang SY, et al. Screening for fear of cancer recurrence: Instrument validation and current status in early stage lung cancer patients. J Formos Med Assoc. 2020;119:1101-8.

Nandakumar D, Veeriah S, Krishnamurthy A, Veluswami S, Ananthi B. Fear of cancer recurrence 7 scale tamil translation and validation among breast cancer survivors in India. Indian J Palliat Care. 2022;28:321-7.

Bergerot CD, Ferreira LN, Molina LN, Pagung LB, Pedersen B da S, de Andrade TG, et al. Fear of cancer recurrence among Brazilian patients with cancer: translation and cultural adaptation of FCR4/7 and FCRI-SF measures. J Psychosom Res. 2023;165:111125.

Pais-Ribeiro J, Silva I, Ferreira T, Martins A, Meneses R, Baltar M. Validation study of a Portuguese version of the hospital anxiety and depression scale. Psychol Health Med. 2007;12:225-37.

Zigmond AS, Snalth RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361-70.

Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. the european organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365-76.

Pais-Ribeiro J, Pinto C, Santos C. Validation study of the portuguese version of the QLC-C30-V.3. Psicologia, Saúde & Doenças. 2008;9:89- 102.

Terwee CB, Bot SD, de Boer MR, van der Windt DA, Knol DL, Dekker J, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60:34-42.

DiStefano C, Liu J, Jiang N, Shi D. Examination of the weighted root mean square residual: evidence for trustworthiness? Struct Equ Modeling. 2018;25:453-66.

Kline RB. Principles and practice of structural equation modeling. New York: The Guilford Press; 2016.

Schermelleh-Engel K, Moosbrugger H, Müller H. Evaluating the fit of structural equation models: tests of significance and descriptive goodness-of-fit measures. MPR Online. 2003;8:23-74.

Schober P, Boer C, Schwarte LA. Correlation coefficients: appropriate use and interpretation. Anesth Analg. 2018;126:1763-8.

Ratner B. The correlation coefficient: Its values range between 1/1, or do they. J Target Meas Anal Mark. 2009;17:139-42.

Hajian-Tilaki K. Receiver operating characteristic (ROC) curve analysis for medical diagnostic test evaluation. Caspian J Intern Med. 2013;4:627-35.

Habibzadeh F, Habibzadeh P, Yadollahie M. On determining the most appropriate test cut-off value: the case of tests with continuous results. Biochem Med. 2016;26:297-307.

Unal I. Defining an optimal cut-point value in ROC analysis: an alternative approach. Comput Math Methods Med. 2017;2017:3762651.

Hu LT, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equ Modeling. 1999;6:1-55.

Brown TA. Confirmatory factor analysis for applied research. New York: The Guilford Press; 2015.

Nahm FS. Receiver operating characteristic curve: overview and practical use for clinicians. Korean J Anesthesiol. 2022;75:25-36.

Cohen J. Statistical power analysis for the behavioral sciences second edition. New Jersey: Lawrence Erlbaum Associates, Inc.:1988.

Byrne BM. Structural equation modeling with AMOS. New York: Routledge: 2010.

Shi D, Lee T, Maydeu-Olivares A. Understanding the model size effect on SEM fit indices. Educ Psychol Meas. 2019;79:310-34.

Peng L, Huang W, Zhang W, Xu Y, Lu F, Zhong L, et al. Psychometric properties of the short form of the fear of cancer recurrence inventory (FCRI) in Chinese breast cancer survivors. Front Psychiatry. 2019;10:1- 7.

Cho D, Park CL. Moderating effects of perceived growth on the association between fear of cancer recurrence and health-related quality of life among adolescent and young adult cancer survivors. J Psychosoc Oncol. 2017;35:148-65.

Thewes B, Kaal SE, Custers JA, Manten-Horst E, Jansen R, Servaes P, et al. Prevalence and correlates of high fear of cancer recurrence in late adolescents and young adults consulting a specialist adolescent and young adult (AYA) cancer service. Support Care Cancer. 2018;26:1479- 87.

Taylor RM, Whelan JS, Gibson F, Morgan S, Fern LA. Involving young people in BRIGHTLIGHT from study inception to secondary data analysis: insights from 10 years of user involvement. Res Involv Engagem. 2018;4:1-14.

Williams JT, Pearce A, Smith A Ben. A systematic review of fear of cancer recurrence related healthcare use and intervention cost-effectiveness. Psychooncology. 2021;30:1185-95.

Downloads

Publicado

2025-03-03

Como Citar

1.
Neves MC, Sales CMD, Oliveira J, Bártolo A, Prins JB, Monteiro S. Avaliar o Medo de Recorrência do Cancro em Adolescentes e Jovens Adultos: A Validação Portuguesa e Avaliação Psicométrica da Escala “Medo de Recorrência do Cancro 7”. Acta Med Port [Internet]. 3 de Março de 2025 [citado 10 de Março de 2025];38(3):148-59. Disponível em: https://actamedicaportuguesa.com/revista/index.php/amp/article/view/22085

Edição

Secção

Original